Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
45results about How to "Enabling delivery" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Method and apparatus providing rapid end-to-end failover in a packet switched communications network
InactiveUS20060002292A1Improve resiliency and availabilityImprove communication performanceError preventionFrequency-division multiplex detailsTraffic volumeTelecommunications link
A hardware-based failover scheme enabling rapid end-to-end recovery is provided. Hardware logic periodically generates, transmits, receives, and processes heartbeat packets, sent from one end of the communications network to another, and then returned back. If a communications network node or communications link failure is being experienced along the transport path, then the hardware logic rapidly swaps the affected traffic conveyed to a pre-established backup transport path, typically within microseconds. Advantages are derived from the rapid failover effected end-to-end which enables continued delivery of provisioned communications services improving the resiliency and / or availability of a communications network.
Owner:SYNAPTICS INC
Devices, systems, and methods for closing the left atrial appendage
ActiveUS20080243183A1Enabling deliveryFacilitate optimal closureSuture equipmentsBalloon catheterPericardial spaceAppendage
Described here are devices, systems and methods for closing the left atrial appendage. Some of the methods described here utilize one or more guide members having alignment members to aid in positioning of a closure device. In general, these methods include advancing a first guide having a first alignment member into the left atrial appendage, advancing a second guide, having a second alignment member, into the pericardial space, aligning the first and second alignment members, advancing a left atrial appendage closure device into the pericardial space and adjacent to the left atrial appendage, and closing the left atrial appendage with the closure device. In these variations, the closure device typically has an elongate body having a proximal end and a distal end, and a closure element at least partially housed within the elongate body. The closure element comprises a loop defining a continuous aperture therethrough.
Owner:SENTREHEART LLC
Navigation system and method
ActiveUS20060287815A1Easy to manipulateEasy to readInstruments for road network navigationRoad vehicles traffic controlRoad mapComputer graphics (images)
A novel mapping paradigm is provided for the visual display of information in the form of an improved navigational aid. Unlike today's road maps which use a point-arc-polygon paradigm, the new mapping paradigm uses a compressed linear-pictographic-topological design that typically depicts roads as vertical linear pictograms. Further, the display has a columnar layout, whereby the descriptive elements are grouped together by type, and displayed one above the other in columns. In this manner, the mapping paradigm also serves to increase traveler safety, provide navigation assistance during address-less trips, create valuable advertising space and new promotional opportunities, and dramatically increases the travelers' communications and entertainment options.
Owner:NYTELL SOFTWARE LLC
Navigation system and method
ActiveUS7711478B2Reduce loadReduce fatigueInstruments for road network navigationRoad vehicles traffic controlRoad mapComputer graphics (images)
Owner:AI-CORE TECH LLC
Biocompatible polymer compositions for dual or multi staged curing
ActiveUS20050197422A1Increase ratingsHigh viscosityCosmetic preparationsImpression capsWound healingBioadhesive
The present invention provides a biocompatible polymer composition for use in biomedical applications comprising a base molecule, a linker molecule and at least one initiator compound, said base molecule having at least two differing functionalities, and said linker molecule having a functionality reactive with at least one functionality of said base molecule, the first of said at least two functionalities of said base molecule enabling a first curing stage of said polymer composition by reaction with said linker molecule, and the second and any further functionality of said base molecule enabling second and further curing stages of said polymer composition, said first, second and any further curing stages being capable of activation simultaneously or independently of each other as required. The invention further provides uses of the polymer compositions of the invention in biomedical applications such as tissue engineering, dry delivery, as a bioadhesive in wound healing, as bone substitutes or scaffolds, as cements in dental and periodontal applications and as anti-adhesives or protective barriers.
Owner:POLYNOVO BIOMATERIALS PTY LTD
Aerosol and injectable formulations of nanoparticulate benzodiazepine
InactiveUS20060198896A1Easy doseReduce injection volumeBiocidePowder deliveryBenzodiazepinePolyethylene glycol
Described are nanoparticulate formulations of a benzodiazepine, such as lorazepam, that does not require the presence of polyethylene glycol and propylene glycol as stabilizers, and methods of making and using such formulations. The formulations are particularly useful in aerosol and injectable dosage forms, and comprise nanoparticulate benzodiazepine, such as lorazepam, and at least one surface stabilizer. The formulations are useful in the treatment of status epilepticus, treatment of irritable bowel syndrome, sleep induction, acute psychosis, and as a pre-anesthesia medication.
Owner:ELAN PHRMA INT LTD
Navigation system and method
ActiveUS20100318291A1Easy access to informationEasy to manipulateInstruments for road network navigationDrawing from basic elementsRoad mapComputer graphics (images)
A non-scaled, linearly compressed pictographic mapping system is provided for the visual display of information in a navigational aid. Unlike today's road maps which use a point-arc-polygon paradigm, the new mapping uses a non-scaled, linearly-compressed pictographic design that shows roads as linear pictograms. The display has a columnar layout, whereby the descriptive elements are grouped together by type, and displayed one above the other in columns. The maps may also contain icons representing points of interest arranged in a cloud fashion. In this manner, the mapping paradigm also serves to increase traveler safety, provide navigation assistance during address-less trips, create valuable advertising space and new promotional opportunities, and dramatically increases the travelers' communications and entertainment options.
Owner:NYTELL SOFTWARE LLC
Devices, systems, and methods for closing the left atrial appendage
ActiveUS20090143791A1Enabling deliveryFacilitate optimal closureSuture equipmentsBalloon catheterPericardial spaceAppendage
Described here are devices, systems and methods for closing the left atrial appendage. Some of the methods described here utilize one or more guide members having alignment members to aid in positioning of a closure device. In general, these methods include advancing a first guide having a first alignment member into the left atrial appendage, advancing a second guide, having a second alignment member, into the pericardial space, aligning the first and second alignment members, advancing a left atrial appendage closure device into the pericardial space and adjacent to the left atrial appendage, and closing the left atrial appendage with the closure device. In these variations, the closure device typically has an elongate body having a proximal end and a distal end, and a closure element at least partially housed within the elongate body. The closure element comprises a loop defining a continuous aperture therethrough.
Owner:SENTREHEART LLC
Drug delivery apparatus
ActiveUS20080009836A1Reduce rateEnabling deliveryElectrotherapyEar treatmentBody fluidBiomedical engineering
An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a body cavity of a patient over a period of time includes a variable-volume vessel defining a working chamber for receiving a drug and recirculating a therapeutic fluid. The fluid can contain a bodily fluid, such as, for example, perilymph, and a drug. The device allows for the controlled delivery of the therapeutic fluid to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear.
Owner:CHARLES STARK DRAPER LABORATORY
Method, system and apparatus for delivering enhanced programming information
InactiveUS20090300674A1Enabling deliveryIncrease heightTelevision system detailsPulse modulation television signal transmissionComputer scienceReal-time computing
A method, system and apparatus for delivering enhanced programming information. In some non-limiting embodiments the method comprises obtaining channel grid information for identifying a programming event, the programming event being associated to an occurrence interval. The method further comprises receiving a dynamic program description associated with the programming event. Receiving of the dynamic program description is executed during the occurrence interval associated to the programming event. The channel grid information is then augmented with the dynamic program description. The disclosed method, system and apparatus enable the subscriber to ascertain the current status of the programming event occurring on one or more channels to potentially enable the subscriber to make a more informed decision as to which specific programming event to select for viewing.
Owner:BCE
Navigation system and method
ActiveUS8670925B2Reduce loadReduce fatigueInstruments for road network navigationDrawing from basic elementsRoad mapComputer graphics (images)
A non-scaled, linearly compressed pictographic mapping system is provided for the visual display of information in a navigational aid. Unlike today's road maps which use a point-arc-polygon paradigm, the new mapping uses a non-scaled, linearly-compressed pictographic design that shows roads as linear pictograms. The display has a columnar layout, whereby the descriptive elements are grouped together by type, and displayed one above the other in columns. The maps may also contain icons representing points of interest arranged in a cloud fashion. In this manner, the mapping paradigm also serves to increase traveler safety, provide navigation assistance during address-less trips, create valuable advertising space and new promotional opportunities, and dramatically increases the travelers' communications and entertainment options.
Owner:AI-CORE TECH LLC
Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
ActiveUS20070178070A1Suitable storage shelf-lifeAvoid any substantial degradationBiocideNervous disorderOral medicationDelivery vehicle
The present invention comprises methods and compositions for the reduction of oxalate in humans, animals and plants. For example, the invention provides methods and compositions for the delivery of one or more oxalate-reducing pharmaceutical compositions to the intestinal tracts of persons and animals. The methods and compositions can be used in treating and preventing oxalate-related conditions. A composition of the invention comprises an oral delivery vehicle comprising an oxalate degrading bacteria, one or more cryopreserving agents and one or more excipients. A composition of the invention is enteric coated and has a suitable shelf-life and acceptable properties to avoid negative impact from gastric fluid when it is orally administered.
Owner:OXTHERA INTPROP
Methods and system for device-to-device communication
ActiveUS20190246385A1Overcome disadvantagesEnabling deliveryTransmission path divisionSignal allocationResource poolCommunications system
An advanced wireless communication system, and a method for use at an advanced wireless communication system are disclosed that support direct communication to provide flexible resource pool sharing. The method comprises: measuring, at a first UE, utilization of at least one resource pool of a direct communication channel associated with a configured shared region; transmitting, by the first UE and to at least one second UE, sidelink control information (SCI) identifying a selected resource pool of the at least one resource pool; and transmitting, by the first UE and to the at least one second UE, data associated with the SCI in the selected resource pool.
Owner:NEC CORP
Navigation system and method
ActiveUS20100305847A1Reduce loadReduce fatigueInstruments for road network navigationRoad vehicles traffic controlRoad mapComputer graphics (images)
A non-scaled, linearly compressed pictographic mapping system is provided for the visual display of information in a navigational aid. Unlike today's road maps which use a point-arc-polygon paradigm, the new mapping uses a non-scaled, linearly-compressed pictographic design that shows roads as linear pictograms. The display has a columnar layout, whereby the descriptive elements are grouped together by type, and displayed one above the other in columns. The maps may also contain icons representing points of interest. In this manner, the mapping paradigm also serves to increase traveler safety, provide navigation assistance during address-less trips, create valuable advertising space and new promotional opportunities, and dramatically increases the travelers' communications and entertainment options.
Owner:AI-CORE TECH LLC
Flexible liquid transport tank with surge dampening baffles
ActiveUS20110272413A1Enabling deliveryEliminates wasted flightLarge containersItem transportation vehiclesAirbag deploymentEngineering
Flexible tanks for transporting liquids comprising a flexible bladder to contain liquid, several transverse surge dampening baffles inside the bladder, each baffle comprising several flexible panels, each having a base connected to the inside of the bladder and aligned along a plane transverse to the bladder and an unsupported terminal end opposite the base and adapted to converge with the unsupported portions of adjacent panels in a manner that defines a barrier to fluid flow across the transverse baffle when the bladder is filled; and a connector for interconnecting the terminal ends of the panels. There may be provided a flexible outer bladder of an abrasion resistant material that is adapted to removably receive the inner bladder. There may be provided longitudinal baffles situated between adjacent transverse baffles that define longitudinal compartments with restricted fluid flow there between for dampening lateral fluid surges.
Owner:DONMARK HLDG
High Solids Fermentation for Synthesis of Polyhydroxyalkanoates From Gas Substrates
InactiveUS20120028321A1Simple and economic techniqueLow cost productionFermentationMicroorganismGas phase
Production of polyhydroxyalkanoates (PHAs) is performed by delivering substrates such as methane in gas phase during a high solids fermentation. Microorganisms are grown under balanced conditions, then gas phase substrates are delivered under unbalanced conditions to produce PHA granules inside the cells. The cells containing these granules are lysed and the bioplastic powder recovered. The balanced phase growth may occur in submerged liquid cultures or attached as biofilms to a surface.
Owner:CRIDDLE CRAIG S +3
Drug delivery apparatus
ActiveUS7867193B2Reduce rateEnabling deliveryElectrotherapyEar treatmentPharmaceutical drugBody fluid
An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a body cavity of a patient over a period of time, which includes a hollow member that defines at least one lumen for facilitating a unidirectional recirculating flow of a therapeutic fluid through the lumen. The fluid can contain a bodily fluid, such as, for example, perilymph, and a drug. The apparatus also includes a pump, for example a single unidirectional pump, to control the flow rate of the therapeutic fluid through the hollow member, and an interface member in communication with at least one lumen of the hollow member. The device thus allows for the controlled delivery of the therapeutic fluid to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear.
Owner:MASSACHUSETTS EYE & EAR INFARY +1
Aerosol and injectable formulations of nanoparticulate benzodiazepine
InactiveUS20090304801A1Easy to atomizeFacilitate depositionPowder deliveryBiocideBenzodiazepineNanoparticle
Described are nanoparticulate formulations of a benzodiazepine, such as lorazepam, that does not require the presence of polyethylene glycol and propylene glycol as stabilizers, and methods of making and using such formulations. The formulations are particularly useful in aerosol and injectable dosage forms, and comprise nanoparticulate benzodiazepine, such as lorazepam, and at least one surface stabilizer. The formulations are useful in the treatment of status epilepticus, treatment of irritable bowel syndrome, sleep induction, acute psychosis, and as a pre-anesthesia medication.
Owner:ELAN PHRMA INT LTD
Cell-Targeted IKB and Methods for the Use Thereof
InactiveUS20070202593A1Improve abilitiesEnabling deliveryAntibody mimetics/scaffoldsImmunoglobulins against cell receptors/antigens/surface-determinantsPopulationCytotoxic Therapy
Activation of nuclear factor kB (NF-kB) is involved in a number of diseases such as viral and bacterial infections, and cell proliferative disorders such as cancer and autoimmune disease. In certain instances, constitutive NF-kB activity has also been liked to the resistance of certain cancers to chemo and radiation therapy. The instant invention concerns method of inhibiting NF-kB activity in target cell populations by deliver of a polypeptide inhibitor of NF-kB (IkB). Methods of the invention may be used to treat diseases such as infections, and cell proliferative disorders. Methods for sensitizing cells to apoptosis and cytotoxic therapies are also described.
Owner:RES DEVMENT FOUND
Riser release flaring system for parafoils
ActiveUS20170297724A1Large internal pressureImprove performanceParachutesNon-rigid airshipsLine tubingFlight vehicle
Described herein are features for a riser release flaring system for parafoils and other descent flight vehicles for controlled descent and landing of the flight vehicle. The descent flight vehicle may have a payload suspended by a canopy. The descent flight vehicle may be released from a high altitude lighter-than-air (LTA) system, from another system, or may not be associated with any other flight system. The riser release auto flare system is used with the descent system, such as the parafoil, for controlled and safe landing of the payload. Riser lines are released at a controlled rate and for a fixed distance to automatically cause the payload to pull control lines to flare the parafoil and slow a descent and / or forward speed of the vehicle. The riser lines may be released in response to the descent system satisfying a landing criterion, such as altitude.
Owner:WORLD VIEW ENTERPRISES
Accreditation maintenance through remote site monitoring
InactiveUS7072931B2Easy to operateEnabling deliveryMultiple digital computer combinationsMedical imagesSite monitoringThe Internet
Methods and systems for remotely monitoring an imaging facility's compliance with accreditation requirements. In a particular embodiment, the present invention remotely monitors the status of an MRI facility. In some configurations, the MRI unit is coupled to a server station. Information from the MRI unit is transmitted and stored on the server station. The information can be transmitted over a network, such as the internet, to a remote server. The remote server can collect and evaluate the accreditation data.
Owner:GOLDHABER DAVID +2
Portable terminal with speaker device
ActiveUS8351638B2Improve an aesthetic styleHigh-quality sound reproductionTransmissionTelephone set constructionsEngineeringLoudspeaker enclosure
Owner:SAMSUNG ELECTRONICS CO LTD
Scalable parallel gene therapy injector array
InactiveUS8708965B2Enabling deliveryWide applicabilityCellsSludge treatmentDisplacement controlBiomedical engineering
A scalable parallel injector array has a support structure for holding injector tubes in a spatial pattern in order to enable delivery of fluidic materials simultaneously to a group of specific target areas in the brain or a body part. Each injector is individually connectible at one end to a displacement-controlled pump and is designed at the other end to be inserted into the brain or body part. The injector tubes are connected to the pump by fluid-filled tubing. The spatial pattern is patient- and / or application-customizable, and the length of the injector tubes is customizable in order to more precisely reach individual target areas. A clamping device may be used to attach the injector array to a stereotaxic arm or other support structure. The action of the pump permits controlled simultaneous delivery of the fluidic materials to the target areas.
Owner:MASSACHUSETTS INST OF TECH
Medicine reservoir for drug delivery device
ActiveUS20130197440A1Enabling deliveryEasy to disassembleMedical devicesDrug StorageBiomedical engineering
A medicine reservoir (10) is provided for use with a drug delivery device (50). The medicine reservoir (10) is arranged for comprising a drug (13) and comprises a dispensing hole (15) for dispensing the drug (13) into an environment of the drug delivery device (50). The medicine reservoir (10) further comprises a deformable plug (14) which plug (14) is removable by pressure caused by a dispensing action of the drug delivery device (50).
Owner:BIORA THERAPEUTICS INC
Method and system for computer-implemented trading of secondary market debt securities
ActiveUS7526443B2Easy to set upProvide securityFinancePayment architectureIndication of interestSecurity question
A computer-implemented method and system for trading of debt securities (bonds), where multiple dealers participate and compete on a single platform (100). Dealers and investors have respective interfaces (250, 230) for communicating. In one aspect, dealers announce new debt security issues (400), the investors communicate an indication of interest (IOI) (500) in purchasing the new debt security issues, and the issues are allocated to the investors. In another aspect, issues from multiple dealers are made available to investors on a secondary trading market in a searchable format (1000). In response to price inquiries sent by the investors (1200), the dealers provide offers (1300) which are briefly held and released to the investor concurrently to allow the investor to consider all offers together. In another aspect, the dealers post bid and offer terms for actively traded issues (1700) that are updated in real-time to avoid the need for the inquiry procedure.
Owner:MARKETAXESS HLDG
Riser release flaring system for parafoils
ActiveUS9868537B2Slow landingSlow down the landing speedParachutesBalloon aircraftsFlight vehicleClassical mechanics
Owner:WORLD VIEW ENTERPRISES
pH dependent release coated microparticle cannabinoid formulations
ActiveUS11160757B1Prevent degradationEnabling deliveryDispersion deliveryHydroxy compound active ingredientsCannabinoidOrganic chemistry
The present disclosure provides a microparticulate comprising one or more cannabinoids and a pH dependent release polymer. In embodiments, the one or more cannabinoids are present in an amount ranging from 10% w / w to about 50% w / w. In embodiments, the pH dependent release polymer is present in an amount ranging from ranging from about 5% w / w to about 85% w / w.
Owner:GW RES LTD
Method and System Configured for Facilitating Management of International Trade Receivables Transactions
InactiveUS20080222639A1Improve accuracyIncrease operational efficiency and collaborationFinanceMultiprogramming arrangementsData combinationThird party
Owner:TRADETECH
Prosthesis, delivery system and method for neurovascular aneurysm repair
The present invention is directed to a prosthesis for treating an aneurysm, and delivery systems and methods therefor. The prosthesis includes a radially expanding distal section coupled to a helical section, the helical section including a localized feature configured to exclude or retard blood flow into an aneurysm. Methods of loading the prosthesis onto a specially-designed delivery system that facilitates proper orientation of the prosthesis within a target vessel, and methods of using the delivery system to deliver the prosthesis, also are provided.
Owner:NOVOSTENT CORP
Targeting agent for tumor site
ActiveUS20130017147A1High blood retention propertyEnabling deliveryDiagnostic recording/measuringSensorsCell adhesionPharmaceutical drug
It is an object of the present invention to provide a targeting agent, which enables the delivery of a drug to tumor sites or the imaging of tumor sites by utilizing its effect of accumulating to such tumor sites. The present invention provides a targeting agent for tumor site, which comprises a hydrophilic polymer-modified carrier coated with a gelatin-like protein that has repeats of a sequence represented by Gly-X—Y characteristic to collagen and has two or more sequences of cell adhesion signals in a single molecule wherein X and Y each independently represent an amino acid and a plurality of Gly-X—Y sequences may be the same or different.
Owner:FUJIFILM CORP
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com